US healthcare technology company Ro has raised $500m in new capital to grow its vertically integrated primary care platform.

The Series D funding round was led by existing investors General Catalyst, FirstMark Capital and TQ Ventures along with existing investors SignalFire, Torch Capital and BoxGroup.

New investors that took part in the round are Altimeter Capital, Baupost Group, Dragoneer Investment Group, ShawSpring Partners, Radcliff, and 776.

Since 2017, when the company was founded, Ro has raised a total of $876m in funding.

The company intends to use the funds to build new capabilities and strengthen its existing abilities in telehealth services, pharmacy distribution, and in-home care delivery.

In addition, it will work on improving its proprietary EMR (the Ro Collaborative Care Center), and pharmacy distribution network.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Ro co-founder and CEO Zachariah Reitano said: “Ro is the only company to combine a nationwide telemedicine, pharmacy distribution, and in-home care network.

“Through this vertically integrated platform we’re making high-quality care available when and where patients need it, with no insurance required so patients are the ones in control. We’re powering a patient revolution, and we’re just getting started.”

In December 2020, the company acquired Workpath software platform. This deal allowed Ro to integrate virtual and in-home care delivery on its vertically-integrated platform.

The company’s Covid-19 Vaccine Drive programme, which was recently introduced, is currently active in select Yonkers zip codes in New York.

Recently, it has also collaborated with healthcare AI company Gauss to provide the latter’s smartphone-powered, at-home Covid-19 rapid antigen tests on its platform.